Carprogesic Tablets are white/off white circular tablet for oral administration. Carprogesic Tablets are available in two strengths with the following active composition:20mg Carprofen 50mg Carprofen.

Carprogesic Tablets are indicated for the reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease in dogs.

As a follow up to parenteral analgesia in the management of post-operative pain. Dosage and administration For oral administration to dogs. 4 mg carprofen per kg bodyweight per day. An initial dose of 4 mg carprofen per kg bodyweight per day given as a single daily dose or in two equally divided doses. The daily dose may be reduced, subject to clinical response. Duration of treatment will be dependent upon the response seen. Long-term treatment should be under regular veterinary supervision. Do not exceed the stated dose.

To extend analgesic and anti-inflammatory cover post-operatively parenteral pre-operative treatment with an injectable carprofen product may be followed with carprofen tablets at 4 mg/kg/day for 5 days. Contra-indications, warnings, etc Do not use in cats. Do not use in pregnant or lactating bitches.

Do not use in puppies less than 4 months of age. Do not use in case of hypersensitivity to active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia.

Use in aged dogs may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical management. Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity. Concurrent administration of potential nephrotoxic drugs should be avoided.

In the absence of any specific studies in pregnant target bitches, such use is not indicated. NSAIDs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infection, appropriate concurrent antimicrobial therapy should be instigated. Do not administer NSAIDs concurrently or within 24 hours of each other.

Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs, which can lead to toxic effects. Typical undesirable effects associated with NSAIDs such as vomiting, soft faeces/diarrheoa, faecal occult blood, loss of appetite and lethargy have been reported.

These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal. If adverse reactions occur, use of the product should be stopped and the advice of a veterinarian should be sought.

As with other NSAIDs there is a risk of rare renal or idiosyncratic hepatic adverse events. The safety of the veterinary medicinal product has not been established during pregnancy and lactation. Do not use in pregnant or lactating bitches.

In the event of accidental ingestion of the tablets, seek medical advice and show the doctor the package leaflet.Wash hands after handling the product. Pharmaceutical precautions Do not store above 25°C. Store in a dry place.

Dispose of used packaging in the household refuse. Unused product should be returned to the veterinary surgeon. Keep out of reach and sight of children.

For animal treatment only.